Concepedia

Rachel Sikorski

RS

Statistics

Publications

14

Citations

1K

H-Index

14

Active since

2005

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

National Cancer Institute

Stanford University

Discovery Institute

Rachel Sikorski is an author at University of Pittsburgh specializing in pharmacology, medicine, and oncology.

Publications per year

2005–2011

14

Publications

14

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer

David B. Solit, S. Percy Ivy, Catherine Kopil et al. · Clinical Cancer Research · 2007 · 212 citations

Medicine, Pharmacokinetics, Pharmacology +17

The Benzo[c]phenanthridine Alkaloid, Sanguinarine, Is a Selective, Cell-active Inhibitor of Mitogen-activated Protein Kinase Phosphatase-1

Andreas Vogt, Aletheia Tamewitz, John Skoko et al. · Journal of Biological Chemistry · 2005 · 184 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +11

A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells

Andreas Vogt, Peter R. McDonald, Aletheia Tamewitz et al. · Molecular Cancer Therapeutics · 2008 · 99 citations

Medicine, Cancer Biology, Pharmacology +15

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1

Baocheng Huang, Rachel Sikorski, David H. Kirn et al. · Gene Therapy · 2010 · 76 citations · Full text

Life Sciences, Immunology, Oncology +16

Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer

Baocheng Huang, Rachel Sikorski, Padma Sampath et al. · Journal of Immunotherapy · 2011 · 61 citations · Full text

Medicine, Immunology, Oncology +13

1–5 of 14